Kusaka M

No ORCID on file · 4 papers in corpus · active 2003-2014

Study types

  • other 3
  • article 1

Condition tags

  • endometriosis 4
other 2014
European journal of pharmacology ·doi:10.1016/j.ejphar.2013.12.001

TAK-385 (relugolix) is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist, which builds on previous work with non-peptide GnRH antagonist TAK-013. TAK-385 possesses higher affinity and more potent antagonis…

other 2010
Bioorganic & medicinal chemistry ·doi:10.1016/j.bmc.2010.05.061

GPR54 is a G protein-coupled receptor (GPCR) which was formerly an orphan receptor. Recent functional study of GPR54 revealed that the receptor plays an essential role to modulate sex-hormones including GnRH. Thus, antagonists of GPR54 are …

article 2006
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1111/j.1525-1438.2006.00236.x

This report describes a rare case of high-grade endometrial stromal sarcoma (ESS) arising from pathologically confirmed endometriosis in the cul-de-sac. A 37-year-old woman presented with irregular menstruation, pelvic pain, and diarrhea. M…

other 2003
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2002-021065

TAK-013 is a novel nonpeptide and orally active GnRH antagonist. We first examined the effect of TAK-013 on GnRH-stimulated LH release using primary-cultured pituitary cells of cynomolgus monkeys. TAK-013 suppressed LH release to below basa…